Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L

International Journal of Molecular Medicine

Volumn 32, Issue 1, 2013, Pages 101-107

  Zhao, Wei Hua ^a   Wu, Sheng Qi ^b   Zhang, Yang De ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Glioblastoma; Growth; Invasion; microRNA 124; PP1R13L

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; MICRORNA 124; PP1RL1L PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR INVASION; UPREGULATION;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICRORNAS; NEOPLASM INVASIVENESS; REPRESSOR PROTEINS;

EID: 84878214332     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1365     Document Type: Article

References (35)

1. Baldi I, Huchet A, Bauchet L and Loiseau H: Epidemiology of glioblastoma. Neurochirurgie 56: 433-440, 2010.
2. Preusser M, de Ribaupierre S, Wöhrer A, et al: Current concepts and management of glioblastoma. Ann Neurol 70: 9-21, 2011.
3. Lang MF, Yang S, Zhao C, et al: Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS One 7: e36248, 2012.
4. Skalsky RL and Cullen BR: Reduced expression of brain-enriched microRNAs in glioblastomas permits targeted regulation of a cell death gene. PLoS One 6: e24248, 2011.
5. Sun Y, Zhao X, Zhou Y and Hu Y: miR-124, miR-137 and miR-340 regulate colorectal cancer growth via inhibition of the Warburg effect. Oncol Rep 28: 1346-1352, 2012.
6. Blenkiron C and Miska EA: miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 16: R106-R113, 2007. (Pubitemid 47241849)
7. Li Y, Zhao S, Zhen Y, et al: A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells. Brain Tumor Pathol 28: 209-214, 2011.
8. Cortez MA, Nicoloso MS, Shimizu M, et al: miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer 49: 981-990, 2010.
9. Chen L, Wang X, Wang H, et al: miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2. Eur J Cancer 48: 3104-3111, 2012.
10. Wu Z, Sun L, Wang H, et al: MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma. PLoS One 7: e47270, 2012.
11. Liu Y, Yan W, Zhang W, et al: MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol Rep 28: 1013-1021, 2012.
12. Li D, Chen P, Li XY, et al: Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 15: 673-682, 2011.
13. Li KK, Pang JC, Ching AK, et al: miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234-1243, 2009.
14. Silber J, Lim DA, Petritsch C, et al: miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14, 2008.
15. Pierson J, Hostager B, Fan R and Vibhakar R: Regulation of cyclin-dependent kinase 6 by microRNA 124 in medulloblastoma. J Neurooncol 90: 1-7, 2008.
16. Xie YK, Huo SF, Zhang G, et al: CDA-2 induces cell differentiation through suppressing Twist/SLUG signaling via miR-124 in glioma. J Neurooncol 110: 179-186, 2012.
17. Xia H, Cheung WK, Ng SS, et al: Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem 287: 9962-9971, 2012.
18. Cai Y, Qiu S, Gao X, Gu SZ and Liu ZJ: iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes. Apoptosis 17: 777-783, 2012.
19. Alsafadi S, Tourpin S, André F, Vassal G and Ahomadegbe JC: P53 family: at the crossroads in cancer therapy. Curr Med Chem 16: 4328-4344, 2009.
20. Bergamaschi D, Samuels Y, Sullivan A, et al: iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133-1141, 2006. (Pubitemid 44470358)
21. Chen J, Xie F, Zhang L and Jiang WG: iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer 10: 694, 2010.
22. Lu B, Guo H, Zhao J, et al: Increased expression of iASPP, regulated by hepatitis B virus X protein-mediated NF-κB activation, in hepatocellular carcinoma. Gastroenterology 139: 2183-2194, 2010.
23. Zhang X, Wang M, Zhou C, Chen S and Wang J: The expression of iASPP in acute leukemias. Leuk Res 29: 179-183, 2005. (Pubitemid 39647513)
24. Pang MS, Chen X, Lu B, et al: Lentiviral vector-mediated doxycycline-inducible iASPP gene targeted RNA interference in hepatocellular carcinoma. Chin J Cancer 29: 796-801, 2010.
25. Lin BL, Xie DY, Xie SB, et al: Down-regulation of iASPP in human hepatocellular carcinoma cells inhibits cell proliferation and tumor growth. Neoplasma 58: 205-210, 2011.
26. Liu Z, Zhang X, Huang D, et al: Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance. Med Oncol 29: 3381-3388, 2012.
27. Jiang L, Siu MK, Wong OG, et al: iASPP and chemoresistance in ovarian cancers: effects on paclitaxel-mediated mitotic catastrophe. Clin Cancer Res 17: 6924-6933, 2011.
28. Li G, Wang R, Gao J, Deng K, Wei J and Wei Y: RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells. Mol Cell Biochem 350: 193-200, 2011.
29. Arocho A, Chen B, Ladanyi M and Pan Q: Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts. Diagn Mol Pathol 15: 56-61, 2006.
30. Aspenström P, Fransson A and Saras J: Rho GTPases have diverse effects on the organization of the actin filament system. Biochem J 377: 327-337, 2004. (Pubitemid 38142188)
31. Shi XB, Xue L, Ma AH, et al: Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells. Oncogene: Oct 15, 2012 (Epub ahead of print). doi: 10.1038/onc.2012.425.
32. Liu T, Li L, Yang W, et al: iASPP is important for bladder cancer cell proliferation. Oncol Res 19: 125-130, 2011.
33. Zhang B, Xiao HJ, Chen J, Tao X and Cai LH: Inhibitory member of the apoptosis-stimulating protein of p53 (ASPP) family promotes growth and tumorigenesis in human p53-deficient prostate cancer cells. Prostate Cancer Prostatic Dis 14: 219-224, 2011.
34. Liu WK, Jiang XY, Ren JK and Zhang ZX: Expression pattern of the ASPP family members in endometrial endometrioid adenocarcinoma. Onkologie 33: 500-503, 2010.
35. Laska MJ, Lowe SW, Zender L, et al: Enforced expression of PPP1R13L increases tumorigenesis and invasion through p53-dependent and p53-independent mechanisms. Mol Carcinog 48: 832-842, 2009.